Home
Storia in 2 fonti
European pharmaceutical firms criticise Trump tariffs on medicines as ‘blunt instrument’
Trade group says levy will harm patients in US and Europe by reducing access, disrupting supply chains and cutting R&D
- ·
nytimes.com
Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions
Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to higher drug prices.
- ·
theguardian.com
European pharmaceutical firms criticise Trump tariffs on medicines as ‘blunt instrument’
Trade group says levy will harm patients in US and Europe by reducing access, disrupting supply chains and cutting R&D